Y.O. Grusha
I.M. Sechenov First Moscow State Medical University (Sechenov University);
Krasnov Research Institute of Eye Diseases
D.S. Ismailova
Research Institute of Eye Diseases
P.A. Kochetkov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Dysthyroid optic neuropathy: surgical treatment potential
Journal: Russian Annals of Ophthalmology. 2020;136(4): 193‑200
Views: 3680
Downloaded: 36
To cite this article:
Grusha YO, Ismailova DS, Kochetkov PA, Andreeva NA. Dysthyroid optic neuropathy: surgical treatment potential. Russian Annals of Ophthalmology.
2020;136(4):193‑200. (In Russ., In Engl.)
https://doi.org/10.17116/oftalma2020136042193
To evaluate the effectiveness of bony orbital decompression in patients with dysthyroid optic neuropathy (DON).
The study analyzed 255 patients with thyroid eye disease (TED) and bony orbital decompression. Those among them who had DON as an indication for surgery were investigated further. Patients underwent standard ophthalmological examination, computer perimetry, color vision assessment using Ishihara tables, relative afferent pupillary defect (RAPD), computed tomography (CT) of the orbit, and in some cases optical coherence tomography (OCT) of the optic nerve.
Final analysis included 31 patients (52 eyes). On 13 orbits, only lateral wall decompression was performed, and medial wall decompression was the only intervention in 7 orbits. In other cases, these techniques were performed either simultaneously — in 14 orbits, or alternately — in 18 orbits. In the postoperative period, all patients showed significant positive dynamics in terms of visual acuity, visual field, and proptosis. In all cases, decrease of the amount of orbital inflammation was observed. Exophthalmos significantly decreased after surgery and averaged 20.5±3.1 mm, which is 4.7 mm less than the initial one. All changes were statistically significant (p<0.01).
Bony orbital decompression is an effective and safe treatment option for DON resistant to high doses of glucocorticoids. In the vast majority of cases, this intervention is the only way to improve and stabilize visual function in this severe category of patients.
Keywords:
Authors:
Y.O. Grusha
I.M. Sechenov First Moscow State Medical University (Sechenov University);
Krasnov Research Institute of Eye Diseases
D.S. Ismailova
Research Institute of Eye Diseases
P.A. Kochetkov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Received:
29.05.2020
Accepted:
13.06.2020
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.